Cargando…

Laboratory biosafety emergency management for SARS-CoV-2

A biosafety laboratory is a prerequisite for studying emerging infectious diseases. Safe and effective operation in laboratories and the handling of pathogens determine the safety of the personnel, pathogens, and the environment in the laboratory, which are among the key factors for successful exper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Kaili, Liu, Meixuan, Ma, Haoran, Pan, Sidan, Qiao, Hongwei, Gao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501877/ https://www.ncbi.nlm.nih.gov/pubmed/32984781 http://dx.doi.org/10.1016/j.jobb.2020.08.001

Ejemplares similares

The protection of CoronaVac against the infection of wild‐type SARS‐CoV‐2 (WH‐09) or Omicron variant in nude‐hACE2 mice
por: Lin, Kaili, et al.
Publicado: (2023)

The effects of inactivated SARS‐CoV‐2 vaccination and subsequent infection of pregnant mice on the behaviors of offspring
por: Lin, Kaili, et al.
Publicado: (2022)

Current approaches in laboratory testing for SARS-CoV-2
por: Xu, Yuzhong, et al.
Publicado: (2020)

Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory
por: Wang, Qin, et al.
Publicado: (2016)

Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection
por: Murillo-Zamora, E., et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2
por: Beyer, Robert M., et al.
Publicado: (2021)

SARS-CoV-2/COVID-19 laboratory biosafety practices and current molecular diagnostic tools
por: Nyaruaba, Raphael, et al.
Publicado: (2021)

The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory—SARS-CoV-2
por: Blacksell, Stuart D., et al.
Publicado: (2023)

Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman
por: Al-Kindi, Nawal, et al.
Publicado: (2021)

Alterations in Laboratory Parameters Related to Disease Severity in Vaccinated Patients Against SARS-CoV-2
por: Lagadinou, Maria, et al.
Publicado: (2022)

Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
por: Ciorba, Andrea, et al.
Publicado: (2020)

Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique
por: Gbaguidi, G.N., et al.
Publicado: (2023)

Laboratory biosafety for handling emerging viruses
por: Artika, I. Made, et al.
Publicado: (2017)

Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19
por: Fournier, Pierre-Edouard, et al.
Publicado: (2020)

SARS-CoV-2 pandemic and epilepsy: The impact on emergency department attendances for seizures
por: Cheli, Marta, et al.
Publicado: (2020)

SARS-CoV-2 pandemic: An emerging public health concern for the poorest in Bangladesh
por: Banik, Rajon, et al.
Publicado: (2020)

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking
por: Donzelli, Sara, et al.
Publicado: (2022)

Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today
por: Sheikh, Javaid Ahmad, et al.
Publicado: (2020)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Emergency Biosafety Management Practice in Laboratory of Shelter Hospital
por: Liu, Yu-song, et al.
Publicado: (2020)

Current Biosafety Considerations in Stem Cell Therapy
por: Mousavinejad, Masoumeh, et al.
Publicado: (2016)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

A novel fingerprint map for detecting SARS-CoV
por: Gao, Lei, et al.
Publicado: (2006)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis
por: Mourya, Devendra T., et al.
Publicado: (2020)

Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
por: Kaufer, Alexa M., et al.
Publicado: (2020)

Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department
por: Nijhuis, R.H.T., et al.
Publicado: (2020)

Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China
por: Yuan, Dan, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
por: Krüttgen, Alexander, et al.
Publicado: (2021)

The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant
por: Eldesouki, Raghda E., et al.
Publicado: (2022)

Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha
por: Čretnik, Tjaša Ž, et al.
Publicado: (2022)

Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice
por: Lin, Kaili, et al.
Publicado: (2022)

Laboratory-acquired SARS raises worries on biosafety
por: Orellana, Claudia
Publicado: (2004)

Favipiravir use for SARS CoV-2 infection
por: Boretti, Alberto
Publicado: (2020)

Sensitivity of SARS‐CoV‐2 to different temperatures
por: Lv, Qi, et al.
Publicado: (2020)

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples
por: Gupta, Akshita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vs14nqvemf3r7krkvkniiuv3ld